Results 191 to 200 of about 59,989 (270)

Advances in Gastroesophageal Reflux Disease Management: Exploring the Role of Potassium-Competitive Acid Blockers and Novel Therapies. [PDF]

Pharmaceuticals (Basel)
Hossa K, Małecka-Wojciesko E.
europepmc   +1 more source

Prenatal Education: Priorities for Perinatal Nurses [PDF]

, 2008
Hanson, Lisa
core   +1 more source

Lymphocytic Esophagitis Mimicking Allergic Esophagitis: A Case Report. [PDF]

Cureus
Nallapareddy RR, Muntazir H, Makker J.
europepmc   +1 more source

Brief of Amici Curiae Former FDA Commissioners Dr. Donald Kennedy and Dr. David A. Kessler in Support of Respondent, Wyeth v. Levine, No. 06-1249 (U.S. Aug. 14, 2008) [PDF]

, 2008
Sabbeth, Kathryn A., Vladeck, David C.
core   +1 more source

A case of intestinal fistula following surgery for a large ovarian tumor complicated by abdominal tuberculosis: a case report and review of the literature. [PDF]

J Med Case Rep
Ji Q.
europepmc   +1 more source

Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole [PDF]

, 2005
Sivero, L.
core  

Current pharmacological and procedural treatments for gastro-oesophageal reflux disease: comprehensive review. [PDF]

BJS Open
Youssef MM, Watson AC, Profitt SA, Allaway M, Ongso Y, Sivakumar J, Kamal AN, Shimamura Y, Thompson SK, Watson DI, Duong CP, Liu DS.   +11 more
europepmc   +1 more source

Angina Pectoris Following Latanoprostene Bunod 0.024% Administration: A Case Report. [PDF]

Cureus
Edakkavil Z, Fazlani M, Longi A, Shaikh A, Sundaram R.   +4 more
europepmc   +1 more source

Epidemiology of dyspepsia and esophagogastroduodenoscopic findings in the era of <i>Helicobacter pylori</i> eradication. [PDF]

World J Gastroenterol
Suzuki S, Kanno T, Koike T, Chiba T, Asanuma K, Kato K, Hatayama Y, Ogata Y, Saito M, Hatta W, Uno K, Imatani A, Masamune A.   +12 more
europepmc   +1 more source

Real-world-evidence, prospective-observational study to evaluate safety and effectiveness of rabeprazole dual-delayed-release capsules in patients with gastroesophageal reflux disease. [PDF]

World J Gastrointest Pharmacol Ther
Lawate P, Chauhan V, Prasad LR, Pawar A, Puranik AG, Bansal A, Koganti A, Jaiswal A, Puradkar P, Jhaveri K.   +9 more
europepmc   +1 more source